Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ELOVL2 Antikörper (N-Term)

ELOVL2 Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB23770 unconjugated
Produktnummer ABIN653138
  • Target Alle ELOVL2 Antikörper anzeigen
    ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))
    Bindungsspezifität
    • 15
    • 8
    • 7
    • 7
    • 5
    • 1
    • 1
    • 1
    AA 1-27, N-Term
    Reaktivität
    • 30
    • 16
    • 1
    Human
    Wirt
    • 45
    Kaninchen
    Klonalität
    • 45
    Polyklonal
    Konjugat
    • 11
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser ELOVL2 Antikörper ist unkonjugiert
    Applikation
    • 31
    • 23
    • 17
    • 13
    • 13
    • 13
    • 5
    • 3
    • 1
    • 1
    Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Homologie
    M
    Aufreinigung
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This ELOVL2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-27 amino acids from the N-terminal region of human ELOVL2.
    Klon
    RB23770
    Isotyp
    Ig Fraction
  • Applikationshinweise
    WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Haltbarkeit
    6 months
  • Meller, VAN Ellen, Gevensleben, Bicker, Hankeln, Gorr, Sailer, Dröge, Schröck, Bootz, Schröck, Perner, Dietrich, Kristiansen: "Ectopic Myoglobin Expression Is Associated with a Favourable Outcome in Head and Neck Squamous Cell Carcinoma Patients." in: Anticancer research, Vol. 36, Issue 12, pp. 6235-6241, (2017) (PubMed).

  • Target
    ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))
    Andere Bezeichnung
    ELOVL2 (ELOVL2 Produkte)
    Synonyme
    AI317360 antikoerper, Ssc2 antikoerper, SSC2 antikoerper, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 2 antikoerper, ELOVL fatty acid elongase 2 antikoerper, Elovl2 antikoerper, ELOVL2 antikoerper
    Hintergrund
    ELOVL2 could be implicated in tissue-specific synthesis of very long chain fatty acids and sphingolipids. This protein may catalyze one or both of the reduction reaction in fatty acid elongation, i.e., conversion of beta-ketoacyl CoA to beta-hydroxyacyl CoA or reduction of trans-2-enoyl CoA to the saturated acyl CoA derivative (By similarity).
    Molekulargewicht
    34585
    Gen-ID
    54898
    NCBI Accession
    NP_060240
    UniProt
    Q9NXB9
Sie sind hier:
Kundenservice